WALTHAM, Mass.--(BUSINESS WIRE)--Aug. 11, 2006--Royal Philips Electronics (NYSE: PHG, AEX: PHI) and BG Medicine have established an alliance in the field of Systems Biology. Under the partnership agreement BG Medicine will collaborate with Philips to develop the next generation of molecular healthcare products for application in areas such as molecular imaging and point-of-care diagnostics. Key to the alliance is BGM’s proprietary systems profiling technologies that identify biomarker sets associated with disease stage, progression and treatment. BG Medicine has granted Philips preferential access to certain of its proprietary technologies and services, and Philips has acquired a minority stake in BG Medicine, which is privately-held and based in Waltham, Massachusetts.
